CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
100 hedge funds and large institutions have $211M invested in Cascadian Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+10
Holders Change %
+11.11%
% of All Funds
2.7%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
27
Increased
38
Reduced
22
Closed
17
Calls
$2.99M
Puts
$1.74M
Net Calls
+$1.26M
Net Calls Change
+$1.26M
Top Buyers
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$36.5M |
| 2 |
QF
2
QVT Financial
New York
|
$1.75M |
| 3 |
BC
3
Broadfin Capital
New York
|
$6.36M |
| 4 |
4
D.E. Shaw & Co
New York
|
$2.04M |
| 5 |
5
First Eagle Investment Management
New York
|
$0 |
